StockNews.AI
GDRX
StockNews.AI
13 days

GoodRx Reports Second Quarter 2025 Results

1. GDRX reported Q2 2025 revenue of $203.1 million and net income of $12.8 million. 2. Adjusted EBITDA reached $69.4 million with a margin of 34.2%.

Earnings
-20.05%Current Return
VS
-0.07%S&P 500
$4.3408/06 04:16 PM EDTEvent Start
$3.4708/07 10:57 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Bullish?

GDRX's revenue and profit growth reflects strong operational performance, similar to past quarterly successes.

How important is it?

Positive earnings indicate financial health, likely influencing market perception of GDRX.

Why Short Term?

Investors may react positively to recent earnings, impacting stock price in the coming weeks.

Related Companies

CVSWBARAD
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading platform for medication savings in the U.S., has released its financial results for the second quarter of 2025. Second Quarter 2025 Highlights Revenue of $203.1 million Net income of $12.8 million; Net income margin of 6.3% Adjusted Net Income1 of $33.9 million; Adjusted Net Income Margin1 of 16.7% Adjusted EBITDA1 of $69.4 million; Adjusted EBITDA Margin1 of.

Related News